KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Other Non-Current Assets: 2015-2025

Historic Other Non-Current Assets for BeOne Medicines (ONC) over the last 8 years, with Sep 2025 value amounting to $136.2 million.

  • BeOne Medicines' Other Non-Current Assets fell 32.30% to $136.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $136.2 million, marking a year-over-year decrease of 32.30%. This contributed to the annual value of $160.5 million for FY2024, which is 28.02% up from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' Other Non-Current Assets is $136.2 million, which was down 15.78% from $161.7 million recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Other Non-Current Assets registered a high of $201.2 million during Q3 2024, and its lowest value of $3.9 million during Q2 2022.
  • In the last 3 years, BeOne Medicines' Other Non-Current Assets had a median value of $160.5 million in 2024 and averaged $163.2 million.
  • In the last 5 years, BeOne Medicines' Other Non-Current Assets crashed by 60.32% in 2022 and then surged by 3,645.85% in 2023.
  • BeOne Medicines' Other Non-Current Assets (Quarterly) stood at $163.0 million in 2021, then tumbled by 53.93% to $75.1 million in 2022, then surged by 66.89% to $125.4 million in 2023, then grew by 28.02% to $160.5 million in 2024, then tumbled by 32.30% to $136.2 million in 2025.
  • Its last three reported values are $136.2 million in Q3 2025, $161.7 million for Q2 2025, and $149.9 million during Q1 2025.